Nancy Smerkanich to chair panel at DIA’s 50th annual meeting

The meeting will be held on June 15 through June 19 in San Diego, CA.  The panel, “Benefit-Risk Assessments of Medicines: Framework Development and Use in Marketing Applications” will focus on overarching benefit-risk frameworks that regulators and industry are using to make decisions concerning drug approvals.

Nancy P. Smerkanich, MSc is an Educational Liaison in the International Center for Regulatory Science and current Regulatory Science doctoral student.